REVERSAL OF GLIOBLASTOMA REPLICATIVE IMMORTALITY IN A TERT PROMOTER MUTATION-DEPENDENT MANNER

被引：0
|
作者：
Mancini, Andrew [1 ]
Xavier-Magalhaes, Ana [2 ]
Woods, Wendy [3 ]
Nguyen, Kien-Thiet [1 ]
Amen, Alexandra [4 ]
McKinney, Andrew [1 ]
Hayes, Josie [1 ]
Song, Jun [3 ]
Costa, Bruno [2 ]
Perez-Pinera, Pablo [3 ]
Costello, Joseph [5 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[2] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal
[3] Univ Illinois, Dept Bioengn, Champaign, IL 61820 USA
[4] Univ Calif Berkeley, Berkeley, CA 94720 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CSIG-38
引用
收藏
页码：57 / 58
页数：2
相关论文
共 35 条
  • [21] TERT promoter mutation: is it enough to call a WHO grade II astrocytoma IDH wild-type glioblastoma?
    Giannini, Caterina
    Giangaspero, Felice
    NEURO-ONCOLOGY, 2021, 23 (06) : 865 - 866
  • [22] Glioblastoma with FGFR3-TACC3 fusion and TERT promoter mutation: A case report and review of the literature
    Zenezan, D.
    Rong, Y.
    Akhtar, I.
    Jhala, N.
    Seth, A.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 527 - 528
  • [23] Predicting TERT promoter mutation using MR images in patients with witd-type IDH1 glioblastoma
    Yamashita, K.
    Hatae, R.
    Hiwatashi, A.
    Togao, O.
    Kikuchi, K.
    Momosaka, D.
    Yamashita, Y.
    Kuga, D.
    Hata, N.
    Yoshimoto, K.
    Suzuki, S. O.
    Iwaki, T.
    Iihara, K.
    Honda, H.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2019, 100 (7-8) : 411 - 419
  • [24] Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation
    Wijnenga, Maarten M. J.
    Maas, Sybren L. N.
    van Dis, Vera
    Tesileanu, C. Mircea S.
    Kros, Johan M.
    Dirven, Linda
    Hazelbag, Hans M.
    Dubbink, Hendrikus J.
    Vincent, Arnaud J. P. E.
    French, Pim J.
    van den Bent, Martin J.
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [25] TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
    Fujimoto, Kenji
    Arita, Hideyuki
    Satomi, Kaishi
    Yamasaki, Kai
    Matsushita, Yuko
    Nakamura, Taishi
    Miyakita, Yasuji
    Umehara, Toru
    Kobayashi, Keiichi
    Tamura, Kaoru
    Tanaka, Shota
    Higuchi, Fumi
    Okita, Yoshiko
    Kanemura, Yonehiro
    Fukai, Junya
    Sakamoto, Daisuke
    Uda, Takehiro
    Machida, Ryunosuke
    Kuchiba, Aya
    Maehara, Taketoshi
    Nagane, Motoo
    Nishikawa, Ryo
    Suzuki, Hiroyoshi
    Shibuya, Makoto
    Komori, Takashi
    Narita, Yoshitaka
    Ichimura, Koichi
    ACTA NEUROPATHOLOGICA, 2021, 142 (02) : 323 - 338
  • [26] Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma
    Matsumura, Nozomi
    Nakajima, Nozomi
    Yamazaki, Tatsuya
    Nagano, Takuro
    Kagoshima, Kaie
    Nobusawa, Sumihito
    Ikota, Hayato
    Yokoo, Hideaki
    NEUROPATHOLOGY, 2017, 37 (01) : 58 - 63
  • [27] TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
    Kenji Fujimoto
    Hideyuki Arita
    Kaishi Satomi
    Kai Yamasaki
    Yuko Matsushita
    Taishi Nakamura
    Yasuji Miyakita
    Toru Umehara
    Keiichi Kobayashi
    Kaoru Tamura
    Shota Tanaka
    Fumi Higuchi
    Yoshiko Okita
    Yonehiro Kanemura
    Junya Fukai
    Daisuke Sakamoto
    Takehiro Uda
    Ryunosuke Machida
    Aya Kuchiba
    Taketoshi Maehara
    Motoo Nagane
    Ryo Nishikawa
    Hiroyoshi Suzuki
    Makoto Shibuya
    Takashi Komori
    Yoshitaka Narita
    Koichi Ichimura
    Acta Neuropathologica, 2021, 142 : 323 - 338
  • [28] The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival
    Shu, Chang
    Wang, Qiong
    Yan, Xiaoling
    Wang, Jinhuan
    CANCER MEDICINE, 2018, 7 (08): : 3704 - 3712
  • [29] The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
    Liu, T.
    Wang, N.
    Cao, J.
    Sofiadis, A.
    Dinets, A.
    Zedenius, J.
    Larsson, C.
    Xu, D.
    ONCOGENE, 2014, 33 (42) : 4978 - 4984
  • [30] The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
    T Liu
    N Wang
    J Cao
    A Sofiadis
    A Dinets
    J Zedenius
    C Larsson
    D Xu
    Oncogene, 2014, 33 : 4978 - 4984
1234